Medsleuth Inc San Francisco, CA - 94109

Medsleuth Inc is categorized under Data Processing and Preparation in San Francisco, CA and active since 2009.

Medsleuth Inc was established in 2009, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Data Processing and Preparation business, which does work in the B2B market, and is classified as a Data Processing and Preparation, under code number 518210 by the NAICS.

If you are seeking more information, feel free to contact Alicia Gruber at the company’s single location by writing to 1080 Chestnut St Apartment 11a, San Francisco, California CA 94109 or by phoning (415) 699-5295. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Medsleuth Inc
Contact Person: Alicia Gruber
Address: 1080 Chestnut St Apartment 11a, San Francisco, California 94109
Phone Number: (415) 699-5295
Website Address: medsleuth.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Data Processing and Preparation
SIC Code: 7374
NAICS Code: 518210
Share This Business:

Medsleuth Inc was started in 2009 to provide professional Data Processing and Preparation under the SIC code 7374 and NAICS code 518210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Alicia Gruber for inquiries that concern Medsleuth Inc by calling the company number (415) 699-5295, as your correspondence is most welcome. Additionally, the physical location of the single location of Medsleuth Inc can be found at the coordinates 37.802905,-122.421094 as well as the street address 1080 Chestnut St Apartment 11a in San Francisco, California 94109.

For its online presence, you may visit Medsleuth Inc’s website at medsleuth.com and engage with its social media outlets through on Twitter and on Facebook.